Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, ALS, and Huntington’s Disease, are on the rise worldwide. Yet, there are no effective therapies to cure, prevent, or treat most of these disorders.
To make progress, we launched the Neurodegeneration Challenge Network (NDCN) — bringing together experimental scientists from diverse research fields, along with computational biologists and physicians, to look at this problem across diseases.
Read how this effort is taking shape through the story of Rebecca and Elizabeth — a pair of NDCN researchers working together to treat and prevent rare neurodegenerative diseases that impact children.
Learn more about how the NDCN empowers scientists to pursue bold ideas in order to accelerate the science of neurodegeneration — and ultimately, the path to treatments.
News
Back to allHow breakthroughs in the science of inflammation could lead to healthier pregnancies
Dr. Jurado and her team hope to learn more about the genes that are active in maternal and fetal immune cells, the cell types they’re found in, and how these...
Solving bottlenecks in cryoET with machine learning
CZ Imaging Institute scientists mark milestone achievement with annotation of over 13,000 tomograms in just 3.5 days
What can plants teach us about treating brain disease?
Two colleagues from MIT’s Department of Biology are teaming up to study how we might borrow a superpower from plants to treat neurodegenerative disease.
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
Cookies and JavaScript are required to access this form.